CATANZARO, DANIELA
 Distribuzione geografica
Continente #
NA - Nord America 2.124
EU - Europa 588
AS - Asia 204
AF - Africa 1
Continente sconosciuto - Info sul continente non disponibili 1
SA - Sud America 1
Totale 2.919
Nazione #
US - Stati Uniti d'America 2.122
IT - Italia 316
CN - Cina 180
SE - Svezia 79
FI - Finlandia 46
DE - Germania 34
UA - Ucraina 32
GB - Regno Unito 23
NL - Olanda 20
RO - Romania 17
IE - Irlanda 10
IN - India 8
KR - Corea 6
CH - Svizzera 4
FR - Francia 4
SG - Singapore 4
SA - Arabia Saudita 3
CA - Canada 2
AT - Austria 1
CZ - Repubblica Ceca 1
EU - Europa 1
HK - Hong Kong 1
MY - Malesia 1
NG - Nigeria 1
PE - Perù 1
PT - Portogallo 1
TR - Turchia 1
Totale 2.919
Città #
Fairfield 307
Chandler 218
Ashburn 198
Ann Arbor 161
Woodbridge 155
Cambridge 138
Padova 131
Houston 130
Wilmington 106
Seattle 89
Princeton 61
Medford 59
Beijing 56
Des Moines 52
Boardman 36
Malo 31
Nanjing 31
Roxbury 28
Helsinki 27
San Diego 21
New Kensington 16
Washington 14
Shenyang 11
Nanchang 10
Hebei 9
Dublin 8
Milan 8
Jinan 7
Jacksonville 6
Guangzhou 5
Norwalk 5
Parma 5
Phoenix 5
Seongnam-si 5
Changsha 4
Falls Church 4
Hangzhou 4
Hefei 4
Jiaxing 4
Naples 4
New York 4
Redwood City 4
Thun 4
Vicenza 4
Borås 3
Haikou 3
Leawood 3
Ningbo 3
Nürnberg 3
Rome 3
Tianjin 3
Torino 3
Zhengzhou 3
Bassano Del Grappa 2
Breganze 2
Cagliari 2
Catania 2
Chengdu 2
Galway 2
Isola di Capo Rizzuto 2
Jeddah 2
Kunming 2
Lendinara 2
Ottawa 2
Silea 2
Taizhou 2
Venezia 2
Acton 1
Amsterdam 1
Andover 1
Aprilia 1
Bologna 1
Bucharest 1
Camponogara 1
Carovigno 1
Central District 1
Chennai 1
Chicago 1
Cinto Caomaggiore 1
Corropoli 1
Dego 1
Dongguan 1
Follina 1
Frattamaggiore 1
Fuzhou 1
Hounslow 1
Indiana 1
Kharkiv 1
Kilburn 1
Kota Bharu 1
Lanzhou 1
Lappeenranta 1
Lima 1
London 1
Marigliano 1
Medina 1
Modugno 1
Palermo 1
Porto 1
Prato 1
Totale 2.277
Nome #
Boswellia serrata Preserves Intestinal Epithelial Barrier from Oxidative and Inflammatory Damage 187
Cisplatin liposome and 6-amino nicotinamide combination to overcome drug resistance in ovarian cancer cells 129
Inhibition of glucose-6-phosphate dehydrogenase sensitizes cisplatin-resistant cells to death 120
A fixed combination of probiotics and herbal extracts attenuates intestinal barrier dysfunction from inflammatory stress in an in vitro model using Caco-2 cells. 112
Effect of Quercetin on Cell Cycle and Cyclin Expression in Ovarian Carcinoma and Osteosarcoma Cell Lines 105
Chlorogenic Acid Interaction with Cisplatin and Oxaliplatin: Studies in Cervical Carcinoma Cells 100
Silybin counteracts doxorubicin resistance by inhibiting GLUT1 expression 95
Protective effects of ψ taraxasterol 3-O-myristate and arnidiol 3-O-myristate isolated from Calendula officinalis on epithelial intestinal barrier 91
Effects of Boswellia Serrata Roxb. and Curcuma longa L. in an In Vitro Intestinal Inflammation Model Using Immune Cells and Caco-2 89
Cell cycle control by natural phenols in cisplatin-resistant cell lines. 85
Isoleucyl-tRNA synthetase levels modulate the penetrance of a homoplasmic m.4277T>C mitochondrial tRNAIle mutation causing hypertrophic cardiomyopathy. 78
Anti-inflammatory activity of Serenoa Repens on human prostate adenocarcinoma cells 76
Attività antinfiammatoria e antiossidante di Boswellia serrata in un modello di epitelio intestinale in vitro. 74
Potential effect of Salvia Haenkey on in vitro wound healing 67
Anti-ageing activity of Salvia haenkei in an in vitro epidermal model 64
Further assessment of Salvia haenkei as an innovative strategy to counteract skin photo-aging and restore the barrier integrity 63
Metabolic profile of cisplatin-resistant phenotype: studies in ovarian carcinoma cell lines. 59
Metabolic and mitochondrial remodelling in cisplatin resistance: studies on ovarian cancer cells and derived cytoplasmic hybrids 57
Metabolic profile of cisplatin-resistant phenotype: studies in ovarian carcinoma cell lines. 55
Metabolic Profile of Cisplatin-resistant Phenotype - Studies in Ovarian Carcinoma Cell Lines 54
Overcome cisplatin -resistance by targetin glucose-6-phosphate dehydrogenase with the combination of liposomal cisplatin and 6-amino nicotinamide 54
SILYBIN: A NATURAL COMPOUND ABLE TO OVERCOME DOXORUBICIN RESISTANCE PHENOMENA 47
Rho0 cells and metabolomic approach to exploit mechanism of resistance to cisplatin in ovarian cancer cell lines. 46
Inhibition of Glucose-6-Phosphate Dehydrogenase Reverses CisplatinResistance: new pharmacological approach using Cisplatin liposome and 6-amino nicotinamide combination 46
Silybin chemosensitize doxorubicin-resistant cells by targeting GLUT1 41
Oxidative stress and metabolic reprogramming: study of pharmacological targets in cellular models of mithocondrial disease. 39
Anti-senescence activity of Salvia Haenkei on a skin cellular model 39
Cannabidiol Isolated From Cannabis sativa L. Protects Intestinal Barrier From In Vitro Inflammation and Oxidative Stress 39
Insight into mitochondrial and metabolic asset of cisplatin resistant ovarian cancer cells. 38
Lipid-metabolic reprogramming in ovarian carcinoma cell lines resistant to cisplatin 38
Effects of genistein on Leber’s hereditary optic neuropathy (LHON) mitochondrial metabolism. 36
Mitochondrial remodeling involved in cisplatin resistance 34
Role of mitochondria in cisplatin-resistance phenomena 34
Cannabis Sativa modulates epithelial permeability in an in vitro intestinal inflammation model 34
Silybin as a new tool to counteract doxorubicin resistance by targeting glucose uptake 33
Cybrid cell model to study the effect of estrogen-like compounds on LHON dysfunctional mitochondria 32
Cannabis Sativa L. modulates epithelial permeability in an in vitro intestinal inflammation model 32
Cisplatin resistance can be curtailed by blunting Bnip3-mediated mitochondrial autophagy 32
Cybrid cell model to study the effect of estrogen-like compounds on LHON dysfunctional mitochondria 31
Mitochondria on Cisplatin resistance: studies on ovarian cancer cells. 30
Natural polyphenol sensitize cancer cells to cisplatin effect on cell cycle 30
Mitochondrial alterations involved in cisplatin resistance phenomena 29
Study of quercetin chemosensitization effect in cisplatin-resistant cancer cell models 29
Natural compounds as metabolic modulators in resistant cancer cells models 29
Quercetin and Cisplatin combined treatment alter cell cycle and sensitize resistant cancer cell lines 29
Mitochondria as cisplatin targets: new apporach to counteract resistance mechanism 28
Natural polyphenols as chemosensitizer: studies in resistant cancer cells. 26
Natural compounds as metabolic modulators in resistant cancer models 26
Molecular mechanism of resistance to cisplatin: study of metabolism in ovarian cancer cells. 24
Natural compounds as metabolic modulators in resistant cancer cell models 23
Calu-3 cells as in vitro model of bronchial epithelium for pharmacological studies of natural compounds 22
Imbalance of mitochondrial "shaping proteins" and cisplatin resistance 22
Study of quercetin chemosensitization effect in cisplatin-resistant cancer cell models 22
Natural polyphenols chemosensitize cisplatin-resistant cells through cell cycle modulation 21
Targeting glucose-6-phosphate dehydrogenase by 6-amino nicotinamide in combination with liposomal cisplatin as a strategy to sensitize ovarian resistant cancer cells 21
Antioxidant and anti-inflammatory activities of Cannabis Sativa in epithelial intestinal cell 19
Silybin glycolysis inhibitor as promising agent in chemotherapy 19
Mithocondria defect and cisplatin resistance: relationships on ovarian cancer cells. 17
Targeting glucose-6-phosphate dehydrogenase with a combination of liposomal cisplatin and 6-amino nicotinamide as new strategy to overcome cisplatin-resistance 16
Silybin, curcumin and quercetin as metabolic modulators in human resistant cancer cells 14
Totale 2.981
Categoria #
all - tutte 9.402
article - articoli 5.042
book - libri 0
conference - conferenze 0
curatela - curatele 0
other - altro 0
patent - brevetti 0
selected - selezionate 0
volume - volumi 0
Totale 14.444


Totale Lug Ago Sett Ott Nov Dic Gen Feb Mar Apr Mag Giu
2018/2019178 0 0 0 0 0 0 0 6 4 56 56 56
2019/2020650 79 28 20 25 56 78 102 68 76 69 32 17
2020/2021408 15 21 10 11 30 9 49 31 46 82 80 24
2021/2022578 15 123 39 16 29 62 21 37 43 10 26 157
2022/2023525 106 34 4 38 126 69 5 34 73 2 22 12
2023/2024301 21 48 43 33 37 62 21 36 0 0 0 0
Totale 2.981